Annual report pursuant to Section 13 and 15(d)

CONSOLIDATED STATEMENTS OF OPERATIONS

v3.20.4
CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2020
Dec. 31, 2019
CONSOLIDATED STATEMENTS OF OPERATIONS    
Revenue, net $ 2,404 $ 1,666
Cost of revenue 1,977 1,737
Gross profit 427 (71)
Operating Expenses:    
Research and development 4,572 5,427
Sales and marketing 2,974 2,834
General and administrative 4,168 2,829
Total operating expenses 11,714 11,090
Loss from operations (11,287) (11,161)
Interest expense, net (1,397)  
Change in fair value of warrant liability 16 204
Change in fair value of derivative liability 0 (171)
Other expense, net (34) (902)
Loss before provision for income taxes (12,702) (12,030)
Provision for income taxes 3 8
Net loss (12,705) (12,038)
Convertible preferred stock dividend (80) (56)
Deemed dividend from warrant repricing (134) 0
Net loss attributable to common stockholders $ (12,919) $ (12,094)
Net loss per common share - basic and diluted $ (2.47) $ (12.75)
Weighted average number of common shares used in computing net loss per common share 5,235,263 948,488